Sensorion SA

XPAR:ALSEN (France)  
€ 0.70 (-1.69%) Apr 30
At Loss
P/B:
3.97
Market Cap:
€ 209.49M ($ 223.95M)
Enterprise V:
€ 175.39M ($ 187.50M)
Volume:
5.36K
Avg Vol (2M):
81.75K
Also Trade In:
Volume:
5.36K
At Loss
Avg Vol (2M):
81.75K

Business Description

Description
Sensorion SA is a France-based clinical-stage biotech company dedicated to the development of therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 12.85
Equity-to-Asset 0.72
Debt-to-Equity 0.09
Debt-to-EBITDA -0.14
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.37
Distress
Grey
Safe
Beneish M-Score -2.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.06
9-Day RSI 38.62
14-Day RSI 40.57
6-1 Month Momentum % 27.11
12-1 Month Momentum % 174.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.21
Quick Ratio 4.21
Cash Ratio 3.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.9
Shareholder Yield % -15.22

Financials

XPAR:ALSEN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sensorion SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 4.743
EPS (TTM) (€) -0.202
Beta 1.11
Volatility % 137.04
14-Day RSI 40.57
14-Day ATR (€) 0.04203
20-Day SMA (€) 0.7236
12-1 Month Momentum % 174.64
52-Week Range (€) 0.26 - 1.04
Shares Outstanding (Mil) 300.12

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sensorion SA Filings

Filing Date Document Date Form
No Filing Data

Sensorion SA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Sensorion SA Frequently Asked Questions

What is Sensorion SA(XPAR:ALSEN)'s stock price today?
The current price of XPAR:ALSEN is €0.70. The 52 week high of XPAR:ALSEN is €1.04 and 52 week low is €0.26.
When is next earnings date of Sensorion SA(XPAR:ALSEN)?
The next earnings date of Sensorion SA(XPAR:ALSEN) is .
Does Sensorion SA(XPAR:ALSEN) pay dividends? If so, how much?
Sensorion SA(XPAR:ALSEN) does not pay dividend.

Press Release

Subject Date
No Press Release